Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Cell Therapy Asia 2018

Shin-Il Kim's Biography

Shin-Il Kim, Director, Division of Research & Development, aceRNA Technologies Co., Ltd.

Shin-Il Kim is currently a director in the division of research & development at aceRNA Technologies Co., Ltd.

He obtained his Ph.D. under the guidance of Prof. Emery Bresnick in Molecular Biology from University of Wisconsin – Madison, U.S.A. in 2008. He then began his studies of TGF-B signaling in cancer model as a postdoctoral fellow with Prof. Derynck Rik at the University of California – San Francisco, U.S.A.

In 2011, he moved to Center for iPS Cell Research and Application (CiRA) at Kyoto University and learned genome engineering techniques in human ES/iPS cells for nearly 7 years with Prof. Woltjen Knut. He became an assistant professor in 2017.

Shin-Il Kim Image

Efficient Detection and Purification of Cell Populations Using RNA Switches

Friday, 7 December 2018 at 08:30

Add to Calendar ▼2018-12-07 08:30:002018-12-07 09:30:00Europe/LondonEfficient Detection and Purification of Cell Populations Using RNA SwitchesCell Therapy Asia 2018 in Kobe, JapanKobe,

We developed synthetic RNA switches for isolating specific cell populations derived from human pluripotent stem cells (PSCs). miR-208a-switch efficiently isolated functional cardiomyocytes and a switch encoding the apoptosis inducer Bim enriched for cardiomyocytes without cell sorting. This approach is broadly applicable, as miRNA switches can be programmed for purification of various cell types. Thus, RNA switches could be useful to purify desired cell types for future therapeutic applications and regenerative medicine.

Add to Calendar ▼2018-12-06 00:00:002018-12-07 00:00:00Europe/LondonCell Therapy Asia 2018Cell Therapy Asia 2018 in Kobe, JapanKobe,